K. Kubota

CODE chemotherapy with and without granulocyte colony-stimulating factor in small-cell lung cancer

M. Fukuoka, N Masuda, Shunichi Negoro et al. · British Journal of Cancer · 1997 · 51 citations · Full text

Medicine, Oncology, Pharmacology +14

Prediction of survival benefits from progression-free survival in patients with advanced non small cell lung cancer: Evidence from a pooled analysis of 2,838 patients randomized in 7 trials

Marc Buyse, Pierre Squifflet, Silvy Laporte et al. · Journal of Clinical Oncology · 2008 · 30 citations

Medicine, Oncology, Pharmacology +14

Japan-SWOG common arm analysis of paclitaxel/carboplatin in advanced stage non-small cell lung cancer (NSCLC): A model for prospective comparison of cooperative group trials

David R. Gandara, Y. Ohe, K. Kubota et al. · Journal of Clinical Oncology · 2004 · 29 citations

Medicine, Oncology, Pharmacology +17

An international, randomized, placebo-controlled, double-blind phase III study (MONET1) of motesanib plus carboplatin/paclitaxel (C/P) in patients with advanced nonsquamous non-small cell lung cancer (NSCLC).

Giorgio V. Scagliotti, Ihor Vynnychenko, Y. Ichinose et al. · Journal of Clinical Oncology · 2011 · 24 citations

Medicine, Oncology, Pharmacology +17

Expression of vascular endothelial growth factor by photodynamic therapy with mono-l-aspartyl chlorin e6 (NPe6) in oral squamous cell carcinoma

Hiroshi Nakagawa, Tomoh Matsumiya, Hirotaka Sakaki et al. · Oral Oncology · 2007 · 19 citations

Medicine, Cancer Biology, Oncology +13